Skip to main content

Table 2 Relationship between CCNI2 expression and tumor characteristics in patients with gastric cancer

From: CCNI2 promotes the progression of human gastric cancer through HDGF

Features No. of patients CCNI2 expression p value
Low High
All patients 93 50 43  
Age (years)     0.331
  < 64 44 26 18  
   ≥ 64 49 24 25  
Gender     0.465
  Male 62 35 27  
  Female 31 15 16  
T Infiltrate     0.201
  T1 6 4 2  
  T2 12 9 3  
  T3 55 27 28  
  T4 20 10 10  
Lymphatic metastasis (N)     0.475
  N0 14 12 2  
  N1 14 6 8  
  N2 20 7 13  
  N3 45 25 20  
Stage     0.020
  I 5 4 1  
  II 22 17 5  
  III 63 26 37  
  IV 3 3 0  
Tumor size     0.960
   < 5 cm 38 20 18  
   ≥ 5 cm 48 25 23  
Lymph node positive     0.911
   ≤ 6 47 25 22  
   > 6 46 25 21  
Vessel carcinoma embolus     0.879
  0 15 8 7  
  1 54 30 24  
Nerve tumor infiltrates     0.884
  0 21 10 11  
  1 18 9 9  
Expression of CD34     0.888
  No 10 6 4  
  Yes 32 20 12  
Expression of EGFR     0.274
  No 69 38 31  
  Yes 13 5 8  
Expression of VEGF     0.025*
    No 39 26 13  
  Yes 43 18 25  
Expression of CDX2     0.202
  No 11 8 3  
  Yes 73 38 35  
Expression of Her2     0.316
  No 64 32 32  
  Yes 19 12 7